PAI-1 4G-4G and MTHFR 677TT in non-hepatitis C virus/hepatitis B virus-related liver cirrhosis

Table 1 Main demographic and clinical characteristics of patients with hepatitis C/B virus liver cirrhosis, defined virus liver cirrhosis and alcoholic and cryptogenic, aggregated as non-virus cirrhosis

	Total (%)	VLC (%)	Alcoholic (%)	Crypto (%)	NVLC (%)
Patients	1079 (100)	729 (100)	102 (100)	248 (100)	350 (100)
Age (range)	57 (19-83)	60 (24-83)	55 (19-80)	49 (19-83)	51 (19-83)
Male sex	620 (57.5)	384 (52.7)	81 (79.4)	155 (62.5)	236 (67.4)
PVT/BCS	352 (32.6)	230 (31.5)	45 (44.1)	77 (31.0)	122 (34.8)
MVT/SVT	53 (4.9)	33 (4.5)	6 (5.8)	14 (5.6)	20 (5.7)
L-M varices	445 (41.2)	574 (78.7)	48 (47.0)	150 (60.4)	245 (70.0)
N° bleeding	360 (33.3)	265 (36.3)	41 (40.1)	54 (21.7)	95 (27.1)
Child A/B/C	416/242/430 (38.5/22.4/39.8)	241/194/294 (33.0/26.6/40.3)	31/53/17 (30.3/51.9/16.6)	129/31/83 (52.0/12.5/33.4)	165/48/17 (47.1/13.7/39.1)

No statistical differences between VLC vs NVLC group: All χ² > 3.85 and P < 0.05. VLC: Virus liver cirrhosis; NVLC: Non-virus cirrhosis; PVT: Portal vein thrombosis; BCS: Budd Chiari syndrome; MVT: Mesenteric vein thrombosis; SVT: Splenic vein thrombosis.